New Hampshire HB1772 allows physicians to administer ibogaine under FDA-approved research protocols and adopts the Physician Associate Licensure.

New Hampshire HB1772 amends state law to permit licensed physicians or qualified licensed practitioners to administer ibogaine under the framework of an FDA-approved research protocol. The bill also adopts the Physician Associate Licensure Compact, which facilitates the mutual recognition of physician associate licenses across participating states. This compact aims to enhance the portability of licenses while safeguarding patient safety. It establishes a commission to oversee the compact, handle disputes, and enforce compliance.

New Hampshire HB1772 allows physicians to administer ibogaine under FDA-approved research protocols and adopts the Physician Associate Licensure.

New Hampshire HB1772 amends state law to permit licensed physicians or qualified licensed practitioners to administer ibogaine under the framework of an FDA-approved research protocol. The bill also adopts the Physician Associate Licensure Compact, which facilitates the mutual recognition of physician associate licenses across participating states. This compact aims to enhance the portability of licenses while safeguarding patient safety. It establishes a commission to oversee the compact, handle disputes, and enforce compliance.